Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT010 vs PT003 vs PT009 in COPD Exacerbations (China)
CTR20160518Phase 3Active
- Sponsor
- Pearl Therapeutics
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Breztri Aerosphere in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Jan 2017; status: active.
02
Drugs
Breztri Aerosphere
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20160518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160518.